In this TV interview, we discuss why so many healthcare experts, cities and states are considering changing their own laws or defying existing ones, in order to help save the lives and health of our fellow citizens.
Prescription for the US opioid crisis: An interview with former congressman Patrick Kennedy (Part 2 of a two part series)
- In this hard hitting, no holes barred interview, former Rhode Island congressman Patrick Kennedy discusses what it will take to successfully combat and reverse our generation’s biggest public health crisis, the opioid epidemic. Does the US have the will for success?
Steve Defossez: What do you think it will it take for this country to develop the political will necessary to actually stem the tide of the opioid crisis?
Patrick Kennedy: Not to sound like a downer but …we couldn’t wrap our arms around the invisible wounds of war for our citizen soldiers the way we need to do to address suicide; (acknowledging the obvious tragedy of 23 soldiers dying a day, in many cases for totally preventable suicides). If we couldn’t get a significant tranche of money for the opioid crisis given the epidemic that’s ongoing, it’s really hard for me to know what it is going to take to spur that kind of political will.
Steve Defossez: Once an effective treatment for HIV-AIDS was discovered, the death rate from HIV-AIDS started coming down right away. Yet similarly effective medication assisted therapies were developed for opioid use disorder years ago, and they have not been widely deployed; hence the death rate from opioid overdose continued to increase.
Patrick Kennedy: The comparisons are that during the HIV-AIDS epidemic, we were spending $24 billion a year to save these patients. And that made a big dent changing the whole fatal nature of HIV-AIDS. Today, we’re spending less than half $1 billion, on the opioid epidemic when we were spending $24 billion on the HIV-AIDS epidemic.
(It should be noted after this interview, Congress passed and the president signed the recent bipartisan spending bill which does include 4 billion dollars to combat the opioid epidemic. This is not allocated solely to fund treatment, however. It also funds opioid prevention, research and law enforcement.)
Steve Defossez: We need to open up people’s eyes to the fact that the genetic predisposition to addiction, like karma, is written indelibly into our genes at the moment of conception. Opioid addiction is as much of a “physical disease” as appendicitis is.
Many patients really want to feel normal again, to get out of the cycle of withdrawal symptoms and use, but they don’t see an alternative to avoid withdrawal besides the use of heroin.
I was told by a hospital CEO in the US Southwest that, when a patient without medical insurance presents to their emergency department with an opioid overdose, they are resuscitated and then immediately discharged back into the community, with no hope of accessing medication assisted therapy, because medication is simply unavailable to patients without insurance in her county. It’s stunning that in a country as rich as ours, which spends 20% of its GDP on healthcare, there is no treatment for these patients.
“And the persistence of this problem is so inexcusable.”
Patrick Kennedy: What’s also stunning is that the hospital CEO wouldn’t follow-up that statement by saying, “and I have therefore made a directive that as hospital CEO, my staff and my doctors will provide that medication assisted treatment, and we are going to work with our local community college to get the necessary peer support specialists etc. We will do that right here on the campus of our hospital.” That’s the appropriate follow-up line. Everyone thinks it needs to be someone else’s job, you know, send them somewhere else. And if they are rich, they can fly to some other part of the country. When in reality, they need to go to their hospital right down the street, where they go for everything else; they need to go there for this care too.
Steve Defossez: And today there isn’t parity. If that patient was pregnant and in labor, they wouldn’t say “oh, you don’t have insurance, leave the hospital.” But for patients suffering from opioid substance use disorder, they do say that.
“Bottom line; hospitals and doctors need to offer medication assisted therapy, as part of their moral responsibility…”
Patrick Kennedy: And the persistence of this problem is so inexcusable. Because as I said the template is pretty simple. They’re going to have an injectable medication. There are several companies coming up with different forms of injectable buprenorphine (medication). All of the insurance companies said they’re going to be reimbursing for this. CMS (Centers for Medicare & Medicaid Services) could easily do a bump up in opioid use disorder reimbursement payment. I’ve talked to them about doing this and they may well be on the track to doing that.
Patrick Kennedy: Bottom line; hospitals and doctors need to offer medication assisted therapy, as part of their moral responsibility, as the chief healthcare provider in the community. It’s hospitals that need to do this, it’s doctors that need to do this.
Patrick Kennedy: The AMA needs to step up. We know it takes eight hours of training to become certified to utilize these medications to treat substance use disorder. Physician organizations should just say you know what? We are going to incentivize that training. We’re going to make payment increases for substance use disorder a top priority. In addition, we are working with the National Council Of Behavioral Health to provide wraparound services. So doctors, you don’t need to do anything but write a prescription for the buprenorphine. Let the community mental health activists and those in the community recovery movement take it from there.
“It’s disappointing that there is so much lack of imagination in the space.”
Patrick Kennedy: This can be put together. I’ve run campaigns, not only for my own case, but for many others, for a long time. We know what the essential elements are for a good campaign. We know how to do it. The playbook is roughly the same. You make some small changes depending on where you are. This is not complicated stuff. It’s not a heavy lift to do. And I guarantee you that a lot of insurance companies would like to do this, because they don’t like the increased costs foisted on the system by undertreatment of opioid addiction.
Patrick Kennedy: With alternative payment models, such as Accountable Care Organizations (ACOs), hospitals and providers are increasingly taking on insurance risk, and are responsible for the total cost of care. They do better financially when they deliver high quality care, utilizing the fewest resources. In an ACO model, hospitals could negotiate increased reimbursement rates for providing mental health treatment and treatment for opioid addiction with these insurers. The rationale would be that we are going to treat the whole person, and be rewarded with lower overall healthcare costs and healthier patients. There are experts who can show that if we treat opioid addiction appropriately, we can easily expect to achieve over a four times lower cost of “physical healthcare” costs. This is the real result of putting somebody into a chronic care management program for addiction.
Patrick Kennedy: There is no rational way to explain why this isn’t already being done. It’s not because we don’t know what to do. It’s not as if we don’t have the reimbursement mechanisms that can be devised to make this a value proposition, especially in this new era of value-based payments. It’s disappointing that there is so much lack of imagination in the space.
“It would be my bet that perhaps one of the single biggest returns on investment in healthcare that we could expect today is to improve the quality of our mental health delivery system, as part of our healthcare system.”
Steve Defossez: Do you think integrated care is the future of mental health and addiction service delivery? What needs to happen to increase its uptake?
Patrick Kennedy: We need to align the financial incentives for optimal outcomes across the entire mental health – physical health spectrum. The optimal outcome is the reduction in the reoccurrence of illness, complications to illnesses and unwanted conditions such as readmissions to the hospital. If mental health issues factors into that, then pay for mental health treatment, at least to the degree that mental health factors into reducing those bad outcomes. It would be my bet that the current lack of mental health treatment factors into contributing to bad health outcomes in a big way.
Patrick Kennedy: In fact, it would be my bet that perhaps one of the single biggest returns on investment in healthcare that we could expect today is to improve the quality of our mental health delivery system, as part of our healthcare system. This is because of how much it’s going to do for the rest of healthcare. I think that unfortunately, the value proposition to cancer will be depression treatment. The value to diabetes could be alcohol treatment. The value to all kinds of intellectual and developmental disabilities will be prenatal care. There are five times as many babies born today with alcohol and drug related complications than there are kids born with autism. The bottom line is, it is integration, integration, integration. Mental health in each and every one of those areas of medicine can be the decisive factor in changing the health of our population.
Steve Defossez: That’s right. 5% of the US public consumes 50% of our healthcare. When you talk to people who work in emergency rooms, there are patients who come into the emergency room several times a week, because of anxiety issues or homelessness and because they don’t have access to more appropriate and less expensive care.
Steve Defossez: A friend of mine is a healthcare CFO in California who noticed one of their patients (who was not particularly ill) was spending $200,000 a year on unnecessary emergency room visits. The patient was checking into the emergency room every two or three days with one complaint or another. When the CFO evaluated the root cause of this behavior, he discovered it was because the patient was homeless. So this CFO somehow arranged to get this patient a stable apartment. The following year, what you think the insurance company spent on his healthcare? The answer is the patient stopped visiting the emergency room altogether. The insurance company didn’t spend one penny on this individual’s health care the following year.
Steve Defossez: I’m not a constitutional scholar but we all know cruel and unusual punishment is banned by the US Constitution. I’m pretty sure if we addicted prisoners of war to opioids and then forced them to go through withdrawal, this would be considered torture. Yet that’s just what we do in the criminal justice system. If someone goes into jail with diabetes, no one thinks twice about giving them insulin. But I understand almost nobody gets medication assisted therapy for opioid use disorder while incarcerated. Hence they’re forced to go through withdrawal and suffer cravings. Particularly with the long acting injectable medications you discussed, proponents of this unconstitutional policy can’t use the argument that these medications might be used illicitly within the prison. Am I wrong that failure to provide medication assisted therapy is a violation of the US Constitution, and a violation of the Parity Act which you spearheaded in Congress?
Patrick Kennedy: That’s right, and then you have the very real incarceration of people with these illnesses and also people with full-blown psychosis, banging their heads against the jailhouse doors. I’ve seen that going into these prisons. We are in a bad place in this country regarding the treatment of people with mental illness including those with addiction.
Steve Defossez: The United States is an outlier in that we incarcerate more people on a percentage basis than any other nation. Part of this is that we incarcerate more people with mental illness than we hospitalize.
Patrick Kennedy: That sounds about right. That’s what we ended up doing, shifting them from the “asylums” to the new asylums which are obviously our jails and prisons.
Steve Defossez: Where you think the future of opioid substance use disorder is headed, including the concept of supervised injection facilities (SIFs)?
Patrick Kennedy: We have long acting buprenorphine in phase 2 trials. Indivior just gained FDA approval for a monthly injection of buprenorphine this past November
Some of the existing long-acting medications come with a catch in that they were administered through a large-bore painful needle. But now they are developing these new long acting injectable medications which can be injected through a tiny needle, like your flu shot. You’d only have to adjust a little bit of titration down from the use of heroin, prior to starting treatment with these medications. These injectables satisfy cravings and protect a person from overdose.
Steve Defossez: Yes, I understand these new long acting buprenorphine medications do not require patients to go through withdrawal or detox before use.
Patrick Kennedy: So it seems to me our first urgency ought to be to get these types of products out, because to your earlier point, people are looking for a way to stop that cycle of in – out, in – out. Substance use followed by detox, followed by substance use then detox. If you can stop the cravings and use, you can prevent them from overdosing. Why isn’t this treatment more widespread? Because it’s out there, it’s not fantasy.
Patrick Kennedy: I understand the harm reduction of supervised injection facilities SIFs, but it’s kind of like what you do when you have no other options. My point is we have these other options, let’s double down on our options, and put these injectables in every doctors’ office in the country, like we do with our flu shots. I know they’ve had success with SIFs in Canada. I’m on my way to Philadelphia now, so I should learn more about SIFs soon.
Steve Defossez: The safe injection facility concept is that people bring in the stuff from the street because they don’t want to stop today but they do want to not die. So they bring it in from the street and this does allow the employees to take microscopic samples of the heroin to see what’s out on the street, whether it’s fentanyl, elephant fentanyl etc. If the person overdoses in the building, they can be resuscitated so they won’t die. And of course because it’s a medical facility, there are staff there who can teach the patient how to inject in a sterile fashion so they don’t get bacterial heart infections, HIV-AIDS, hepatitis etc. While there, patients also have access to first-aid for superficial infections, a warm shower and food. Every encounter is a touch point where someone explains to the patients that when they are ready to choose recovery, we can offer that too.
Patrick Kennedy: I like that. I was very much for safe needles exchange 20 years ago in Providence when I was first a state representative there. And God, it was so hard to get it passed and now, you know, it’s obvious these days.
Conclusion: Every American should awaken to this simple fact: if this scourge has not yet found you or your family, without bold action by everyone, it soon will. I ask you to support cost-effective and life-saving medication assisted therapy by emailing your elected state and federal senators and representative and express your support for adequate funding for and widespread dissemination of this life saving therapy.
Stop the Stigma: Regarding the opioid crisis, there is only “us.” There is no “them.”
It is now understood that some of us, some of you, some of every group have a genetic predisposition to opioid addiction, also known as opioid Substance Use Disorder (SUD). Even exposure to only a few days of certain prescription opioid pain medications can lead to a lifelong addiction to opioids for those of us with this genetic makeup.
You didn’t choose the genetic code written into your chromosomes at the very moment of your conception. Yet it is this karmic destiny which often determines who develops opioid SUD and who does not.
The vast majority of our neighbors with SUD were not led to this condition because they were hopelessly ill, “somehow deranged,” or otherwise “different” from us. These folks are our neighbors, family members, coworkers and friends. They are us.
Over three quarters of heroin addicts had their first exposure to an addictive opioid in the form of a prescription opioid pill. Who has not suffered a traumatic injury, had a tooth extracted, passed a kidney stone, given birth to a child or received a life enhancing joint replacement? For some of us, such routine events, in conjunction with opioid prescriptions, can result in lifelong addiction as surely as night follows day. There but for the grace of God go any of us.
Our graveyards are full of formerly productive students, employees and retirees, who through their own medical prescriptions, developed opioid tolerance, dependence, addiction, overdose and death.
Others in their premature graves first experienced opioids through the bad decision to accept an all-too-available prescription opioid pill from a friend or relative. (Who among us has not made a bad decision?) In the United States, we prescribe 300% to 400% too many opioid pills, which can addict their intended recipients and when diverted, can create new opioid addictions within the public, fueling this horrific epidemic. (Ending opioid over-prescribing will be the subject of a future post.)
Once addicted, patients with SUD become trapped within the vicious cycle of opioid addiction. In time, most patients with SUD are not looking to get high, but rather to stave off the awful symptoms of withdraw, day after terrible day. (What a horrible product; it actually makes its customers physically ill if they don’t keep purchasing the stuff!)
Substance Use Disorder (SUD) is not some kind of moral weakness or a personal failing. It is a chronic physical disease of the brain amenable to successful Medication Assisted Therapy (MAT), just like other chronic physical diseases such as diabetes or hypertension are treatable with medication. We need to make MAT more readily available, as MAT is currently markedly underutilized.
Why should you care? To paraphrase the bipartisan presidential task force upon which former Democratic Congressman Patrick Kennedy and current Republican Governor Charlie Baker just recently served:
Because every American should awaken to this simple fact: If this scourge has not yet found you or your family, without bold action by everyone, it soon will.
Stop the Stigma and please support patient access to Medication Assisted Therapy.
Dead patients can’t recover: Why we need Safe Injection Facilities now
According to the CDC, about 91 Americans die of an opioid overdose every day. That number is too high, and new data has revealed a promising treatment approach–but are we as a society brave enough to accept it?
As a practicing physician and Vice President of Clinical Integration at the Massachusetts Health & Hospital Association (MHA), I serve on the Task Force on Opioid Therapy and Physician Communication at Massachusetts Medical Society (MMS), as well as the MHA’s Substance Use Disorder Prevention and Treatment Task Force.
After careful consideration of the scientific evidence, the multidisciplinary experts of both committees unanimously recognized the merits of a pilot Safe Injection Facility (SIF) project in Massachusetts. Subsequently, this position was ratified by the entire House of Delegates of MMS and unanimously endorsed by the Board of Trustees of MHA.
The end result of opioid Substance Use Disorder (SUD) is recovery, incarceration or death. It turns out most patients with SUD do trend toward recovery, however dead patients can no longer choose to recover. It is up to us to help patients remain alive and healthy until they can choose recovery. SIFs accomplish this by reducing or eliminating the risk of overdose death, as well as the risk of contracting viral diseases such as HIV and hepatitis or bacterial disease such heart infections through contaminated or non-sterile injection practices.
At first, harm reduction strategies such as clean needle exchanges or safe injection facilities may seem counter-intuitive or even counterproductive to the casual observer, bereft of the benefit of the scientific evidence. Yet experience and data informs us of the merits of such strategies.
Not all patients with substance use disorder are ready to choose recovery today. Yet such patients are often amenable to other cost-effective treatments to reduce harm, such as clean needle exchange, access to the opioid reversal agent Naloxone, medical monitoring during intoxication, education and SIFs for safer drug consumption. All of these harm reduction strategies have been proven to reduce the terrible suffering and mortality of this disease and to reduce the expense of treating it.
Benefits of SIFs include:
1. Department of Public Health can sample local heroin and check for contamination.
2. Sterile technique is taught, eliminating infectious disease transmission.
3. If overdose occurs, SIF staff can safely resuscitate the patient.
4. Counseling regarding recovery options is available.
5. SIF patients are more likely to choose recovery.
6. Food, clothing, showers and first aid are available.
7. SIFs save lives until patients choose recovery.
Observing people after they inject drugs has become critical as recently, heroin has been increasingly laced with the deadly drug fentanyl, a narcotic 50 times as potent as heroin. More recently carfentanil laced heroin has appeared on our streets, killing groups of patients in its wake. Carfentanil was originally developed as an elephant tranquilizer. It is 5000 times as potent as heroin. Given the strength of fentanyl, the need for safe injection facilities is even more imperative, as fentanyl and carfentanil overdose victims are more likely to die suddenly. Patients with SUD cannot tell if their heroin is laced with fentanyl.
Perhaps most importantly, SIFs have demonstrated a 30% increase in the rate of patients choosing recovery rather than persistent drug use, as every time a patient utilize an SIF, it’s a touch point for a compassionate healthcare worker to make a personal connection. These touch points increase the client’s awareness of their treatment options.
I can’t emphasize enough the fact that SIF utilization increases the chances that a patient who suffers from SUD will accept referral for treatment, thus taking the first step on the road to recovery rather than their next stride towards an early grave.
This isn’t a question of why spend the money. Safe Injection Facilities save money. A recent Baltimore study predicted that, at an annual cost of $1.8 million, a single SIF would generate $7.8 million in healthcare savings and also prevent untold overdose deaths, HIV and hepatitis infections, hospitalizations for skin and soft-tissue infection and overdose-related ambulance calls and emergency room visits, all while bringing an additional 121 people into addiction treatment.
Another beneficial side effect is that SIFs improve the quality of life within the neighborhoods where they are located, as there is reduced injection related litter, reduced public injecting of drugs and reduced dangerous discarded needles.
We need an all hands on deck strategy to fight this public health epidemic. Harm reduction strategies such as SIFs are one such weapon to combat this crisis. Over half a dozen states are considering legalizing a pilot SIF program. You can save lives, prevent infections and improve communities by supporting SIFs.
Why is it imperative that we pass enabling legislation to pilot SIFs? To paraphrase the report of the bipartisan presidential task force upon which former Democratic Congressman Patrick Kennedy and current Republican Governor Charlie Baker just recently served:
Every American should awaken to this simple fact: if this scourge has not yet found you or your family, without bold action by everyone, it soon will.
I ask you to support this cost-effective and life-saving proposal by emailing your elected state and federal senators and representative and express your support for SIFs.